Fukuda Denshi Co., Ltd. (6960)

Name: Fukuda Denshi Co., Ltd. (6960) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-09-30

Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. The company was founded in 1939 and is headquartered in Bunkyo, Japan.

Dati chiave

Capitalizzazione di mercato: JPY 315 billion
Ricavi (esercizio chiuso a 2026-03-31): JPY 139.7B
Utile netto: JPY 18.8B
Margine lordo: 54.8%
Margine netto: 13.5%

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Entrate totali	JPY 139.7B	JPY 139.0B	JPY 140.3B	JPY 134.6B	—
Utile lordo	JPY 76.5B	JPY 73.8B	JPY 74.4B	JPY 70.4B	—
Risultato Operativo (EBIT)	JPY 26.6B	JPY 25.9B	JPY 26.5B	JPY 24.1B	—
Reddito netto	JPY 18.8B	JPY 18.6B	JPY 18.7B	JPY 17.3B	—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 6960. /companies/us/6960

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.